Loss of miR-146a-5p underlies ibrutinib resistance in mantle cell lymphoma

Identifying why some lymphoma patients resist drug therapy opens doors to better combination treatments.

What the study was

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.